Abstract
Pycnogenol®, an extract of bark from the French maritime pine, Pinus pinaster Ait., consists of a concentrate of water-soluble polyphenols. Pycnogenol® contains the bioflavonoids catechin and taxifolin as well as phenolcarbonic acids. Antioxidants, such as bioflavonoids, enhance endothelial nitric oxide (NO) synthase expression and subsequent NO release from endothelial cells. The purpose of this study was to determine Pycnogenol®'s effects on endothelium-dependent vasodilation in humans. This was a double-blind, randomized, placebo and active drug study. We evaluated forearm blood flow (FBF) responses to acetylcholine (ACh), an endothelium-dependent vasodilator, and to sodium nitroprusside (SNP), an endothelium-independent vasodilator, in healthy young men before and after 2 weeks of daily oral administration of Pycnogenol® (180 mg/day) (n=8) or placebo (n=8). FBF was measured by using strain-gauge plethysmography. Neither the placebo nor Pycnogenol® altered forearm or systemic hemodynamics. Pycnogenol®, but not placebo, augmented FBF response to ACh, from 13.1±7.0 to 18.5±4.0 mL/min per 100 mL tissue (p<0.05). SNP-stimulated vasodilation was similar before and after 2 weeks of treatment in the control and Pycnogenol® groups. The administration of NG-monomethyl-L-arginine, an NO synthase inhibitor, completely abolished Pycnogenol®-induced augmentation of the FBF response to ACh. These findings suggest that Pycnogenol® augments endothelium-dependent vasodilation by increasing in NO production. Pycnogenol® would be useful for treating various diseases whose pathogeneses involve endothelial dysfunction.
Similar content being viewed by others
Article PDF
References
Renaud S, Lorgeril M : Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523–1526.
Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, et al: Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project population. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547–1557.
Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al: Estimation of contribution of changes in classic risk factor to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675–687.
Ross R : Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.
Perticone F, Ceravolo R, Pujia A, et al: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191–196.
Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A : Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948–954.
Schachinger V, Britten MB, Zeiher AM : Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899–1906.
Schäfer A, Chovanova Z, Muchova J, et al: Inhibitor of COX-1 and COX-2 activity by plasma of human volunteers ingestion of French maritime pine bark extract (Pycnogenol®). Biomed Pharmacother 2005; 60: 5–9.
Rohodewald P : A review of the French maritime pink bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002; 40: 158–168.
Williamson G, Manach C : Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005; 81 ( 1 Suppl): 243S–255S.
Liu X, Wei J, Tan F, Zhou S, Wurthwein G, Rohdewald P : Antidiabetic effect of Pycnogenol® French maritime pine bark extract in patients with diabetes type II. Life Sci 2004; 75: 2505–2513.
Panza JA, Quyyumi AA, Buhler FR Jr, Epstein SE : Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.
Higashi Y, Sasaki S, Kurisu S, et al: Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 1999; 100: 1194–1202.
Friedewald WT, Levy RI, Fredrickson DS : Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
Fitzpatrick DF, Bing B, Rohdewald P : Endothelium-dependent vascular effects of Pycnogenol. J Cardiovasc Pharmacol 1998; 32: 509–515.
Ying CJ, Xu JW, Yamori Y, et al: Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II–induced hyperpermeability in endothelial cells. Hypertens Res 2003; 26: 823–828.
Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K : Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002; 346: 1954–1962.
Broere A, Van Den Meiracker AH, Boomsma F, Derkx FH, Man Ina'T Veld, Schalekamp MADH : Human renal and systemic hemodynamics, natriuretic, and neurohumoral responses to different doses of L-NMMA. Am J Physiol 1998; 275: F870–F877.
Neishi Y, Mochizuki S, Miyasaka T, et al: Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration. Proc Natl Acad Sci U S A 2005; 102: 11456–11461.
Imanishi T, Kobayashi K, Kuroi A, Mochizuki S, Goto M, Yoshida K, Akasaka T : Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor. Hypertension 2006; 48: 1058–1065.
Packer L, Rimbach G, Virgili F : Antioxidant activity and biologic properties of procynamidin-rich extract from pine bark, Pycnogenol. Free Radic Biol Med 1999; 27: 704–724.
Devaraj S, Vega-Lopez S, Kaul N, Schonlau F, Rohdewald P, Jialal I : Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 2002; 37: 931–934.
Grimm T, Schafer A, Hogger P : Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol®). Free Radic Biol Med 2004; 36: 811–822.
Goto C, Higashi Y, Kimura M, et al: Effect of deferent intensities of exercise on endothelium-dependent vasodilation in human. Role of endothelium-dependent nitric oxide and oxidative stress. Circulation 2003; 108: 530–535.
Jitsuiki D, Higashi Y, Goto C, et al: Effect of edaravone, a novel free radical scavenger, on endothelium-dependent vasodilation in smokers. Am J Cardiol 2004; 94: 1070–1073.
Maeda K, Yasunari K, Watanabe T, Nakamura M : Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure. Hypertens Res 2005; 28: 755–761.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nishioka, K., Hidaka, T., Nakamura, S. et al. Pycnogenol®, French Maritime Pine Bark Extract, Augments Endothelium-Dependent Vasodilation in Humans. Hypertens Res 30, 775–780 (2007). https://doi.org/10.1291/hypres.30.775
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.30.775
Keywords
This article is cited by
-
Effects of an L-arginine-based multi ingredient product on endothelial function in subjects with mild to moderate hypertension and hyperhomocysteinemia - a randomized, double-blind, placebo-controlled, cross-over trial
BMC Complementary and Alternative Medicine (2017)
-
The effect of an acute antioxidant supplementation compared with placebo on performance and hormonal response during a high volume resistance training session
Journal of the International Society of Sports Nutrition (2014)
